Introduction to Genome Sequencing In Multiple Myeloma
Let's dive into the details surrounding Genome Sequencing In Multiple Myeloma. Mehmet Samur, PhD, Dana-Farber Cancer Institute, Boston, MA, provides an overview of
Genome Sequencing In Multiple Myeloma Comprehensive Overview
Nikhil Munshi, MD, Dana-Farber Cancer Institute, Boston, MA, discusses the growing importance of Francesco Maura, MD, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, discusses a study which used ... Mehmet Samur, PhD, Dana-Farber Cancer Institute, Boston, MA, comments on the value of whole
In this week's video, Dr. Brian G.M. Durie comments on why it is not necessary for
Summary & Highlights for Genome Sequencing In Multiple Myeloma
- Dory Abelman, PhD(c), Princess Margaret Cancer Centre, Toronto, Canada, comments on the potential of cell-free
- At the conclusion of this presentation, the participant should be able to: 1. Understand the concept of mutational signatures. 2.
- Mark Bustoros, MD, Weill Cornell Medicine, New York, NY, discusses
- Francesco Maura, MD discusses the growing importance of whole
- Sarah Gooding, MD PhD, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK, talks on the development of ...
That wraps up our extensive overview of Genome Sequencing In Multiple Myeloma.